Seventh Åland Island Meeting on von Willebrand Disease
ABSTRACT Introduction The seventh Åland Island Meeting on von Willebrand Disease (VWD) was held on the Åland archipelago in Finland, from 26 to 28 September 2024. Aim The meeting brought together experts in the field of VWD from around the world to share the latest advances and knowledge in VWD.
Riitta Lassila +17 more
wiley +1 more source
Pre-arrest oral anticoagulants' impact on cardiac arrest mortality: MIMIC-IV cohort retrospect. [PDF]
Nie X, He L, Zheng X.
europepmc +1 more source
ABSTRACT Background Pulse oximetry is an accurate diagnostic method for assessing the condition of the dental pulp; however, the normal oxygen saturation levels for each tooth type are yet to be clearly defined. Objectives This systematic review and meta‐analysis aims to answer the question: What are the reference values for pulse oximetry testing in ...
Lilian Tietz +3 more
wiley +1 more source
Direct Oral Anticoagulants for Treating Fibrin Sheath-induced Central Venous Port System Dysfunction. [PDF]
Nagata S +13 more
europepmc +1 more source
Safety and Efficacy of LockeT Suture Retention Device for Large‐Bore Venous Access Closure
ABSTRACT Background Electrophysiology (EP) procedures increasingly require large‐bore venous access (LBVA), which is associated with a higher risk of vascular complications. While vascular closure devices (VCDs) are well established for arterial access, data on venous closure—particularly for LBVA—remain limited.
Pedro J. Diaz Delgado +9 more
wiley +1 more source
ABSTRACT Background The left atrial posterior wall (LAPW) is often targeted in atrial fibrillation (AF) ablation due to its shared properties with pulmonary veins. However, substrate‐guided approaches using structural markers have shown inconsistent results.
Michael M. Malaty +7 more
wiley +1 more source
Intravenous Thrombolysis in Patients on Direct Oral Anticoagulants: Analysis of the Get With The Guidelines Stroke Registry. [PDF]
Yaghi S +15 more
europepmc +1 more source
Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial
ABSTRACT Introduction Obesity represents a prevalent condition with multiple comorbidities, including atrial fibrillation (AF). Dronedarone, an antiarrhythmic drug (AAD), has demonstrated efficacy in patients with paroxysmal/persistent AF and cardiovascular (CV) risk factors.
Mate Vamos +3 more
wiley +1 more source
Direct Oral anticoagulants in pulmonary thromboembolism therapy: the generalization-individualization dilemma and the path to risk stratification-a perspective. [PDF]
Meng C, Wang H.
europepmc +1 more source
Data/Design: Nationwide, population‐based longitudinal cohort using the Korean National Health Insurance Service health checkup database (index 2009–2012) with follow‐up through December 31, 2018. Population/Exposure: Adults with diabetes (N = 1,229,689); DFU‐related amputation at baseline (n = 1,486) vs no DFU‐related amputation.
Jinsun Jang +11 more
wiley +1 more source

